Joseph Sinkule - 25 Sep 2025 Form 4 Insider Report for Klotho Neurosciences, Inc. (KLTO)

Role
Chief Executive Officer, Director
Signature
Joseph Sinkule
Issuer symbol
KLTO
Transactions as of
25 Sep 2025
Net transactions value
$0
Form type
4
Filing time
29 Sep 2025, 14:37:28 UTC
Previous filing
08 Aug 2025
Next filing
06 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SINKULE JOSEPH Chief Executive Officer, Director 1300 SOUTH BOULEVARD SUITE D, CHARLOTTE Joseph Sinkule 29 Sep 2025 0001524409

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KLTO Common Stock Other +400,000 +9% 4,846,700 25 Sep 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 25, 2025, the Reporting Person canceled a portion of a previously-reported non-recourse loan, and received the shares back that were pledged as collateral.
F2 Includes 1,000,000 shares issuable upon the exercise of incentive options.